Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Venditti

Showing results (91-100 of 303) with videos related to

Pageof 31
Sort By:
European Journal of Epidemiology|November 1, 1991
Species identification and detection of oxacillin resistance in coagulase-negative Staphylococcus blood isolates from neutropenic patientsM Venditti, S Santilli, P Petasecca Donati, et al.
Cancer Chemotherapy Reports|July 1, 1975
Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943)R J Woodman, R L Cysyk, I Kline, et al.
Chemotherapy|January 1, 1973
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agentsR J Woodman, A E Sirica, M Gang, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 1995
Surveillance study on Staphylococcus aureus in Rome: preliminary data on the frequency of methicillin resistance among nosocomial and community isolatesP Baiocchi, A Capone, R Di Rosa, et al.
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapyA Tarasi, M Cassone, M Monaco, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|August 24, 2012
Laboratory confirmed bloodstream infection aetiology in an intensive care unit: eight years studyG B Orsi, C Franchi, R Marrone, et al.
Cancer Chemotherapy Reports|September 1, 1973
Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962)I Kline, R J Woodman, M Gang, et al.
The Journal of Hospital Infection|July 15, 2006
Hospital-acquired infection surveillance in a neurosurgical intensive care unitG B Orsi, L Scorzolini, C Franchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1972
The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivoR B Field, M Gang, I Kline, et al.
Cancer Chemotherapy Reports|September 1, 1973
Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemiaI Kline, M Gang, R J Woodman, et al.
Pageof 31

Showing results (91-100 of 303) with videos related to

Sort By:
Pageof 31
European Journal of Epidemiology|November 1, 1991
Species identification and detection of oxacillin resistance in coagulase-negative Staphylococcus blood isolates from neutropenic patientsM Venditti, S Santilli, P Petasecca Donati, et al.
Cancer Chemotherapy Reports|July 1, 1975
Enhancement of the effectiveness of daunorubicin (NSC-82151) or adriamycin (NSC-123127) against early mouse L1210 leukemia with ICRF-159 (NSC-129943)R J Woodman, R L Cysyk, I Kline, et al.
Chemotherapy|January 1, 1973
The enhanced therapeutic effect of cis-platinum (II) diamminodichloride against L1210 leukemia when combined with cyclophosphamide or 1,2-bis(3,5-dioxopiperazine-1-yl)propane or several other antitumor agentsR J Woodman, A E Sirica, M Gang, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|March 1, 1995
Surveillance study on Staphylococcus aureus in Rome: preliminary data on the frequency of methicillin resistance among nosocomial and community isolatesP Baiocchi, A Capone, R Di Rosa, et al.
Journal of Chemotherapy (Florence, Italy)|July 19, 2003
Activity of moxifloxacin in combination with vancomycin or teicoplanin against Staphylococcus aureus isolated from device-associated infections unresponsive to glycopeptide therapyA Tarasi, M Cassone, M Monaco, et al.
Annali Di Igiene : Medicina Preventiva E Di Comunita|August 24, 2012
Laboratory confirmed bloodstream infection aetiology in an intensive care unit: eight years studyG B Orsi, C Franchi, R Marrone, et al.
Cancer Chemotherapy Reports|September 1, 1973
Value of cytosine arabinoside (NSC-63878) plus 5-(3,3-dimethyl-1-triazeno)imidazole-4-carboxamide (NSC-45388) therapy in advanced murine L1210 leukemia and enhancement of the combination with sequential doses of methotrexate (NSC-740) or 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU; NSC-409962)I Kline, R J Woodman, M Gang, et al.
The Journal of Hospital Infection|July 15, 2006
Hospital-acquired infection surveillance in a neurosurgical intensive care unitG B Orsi, L Scorzolini, C Franchi, et al.
The Journal of Pharmacology and Experimental Therapeutics|February 1, 1972
The effect of phenobarbital or 2-diethylaminoethyl-2,2-diphenylvalerate on the activation of cyclophosphamide in vivoR B Field, M Gang, I Kline, et al.
Cancer Chemotherapy Reports|September 1, 1973
Protection with N-acetyl-L-cysteine (NSC-111180) against isophosphamide (NSC-109724) toxicity and enhancement of therapeutic effect in early murine L1210 leukemiaI Kline, M Gang, R J Woodman, et al.
Pageof 31